Immunotherapy for Advanced Bladder Cancer : A Giant Step in the Right Direction
WebcastFaculty
OVERVIEW
Immunotherapy for Advanced Bladder Cancer : A Giant Step in the Right Direction is organized by prIME oncology Oncology and will be held during Mar 03, 2017 - Mar 03, 2018.
The target audience for this medical event is specifically designed to meet the needs of practicing medical oncologists, surgical and radiation oncologists, urologists, and other healthcare professionals involved in the treatment of patients with genitourinary malignancies. This CME Conference has been approved for a maximum of 0.5 AMA PRA Category 1 Credits.
Topics:
• Getting to grips with the immune response and cancer treatment
• A step change in the therapeutic options for advanced bladder cancer
• Building on the foundations of success: Rational integration of immunotherapy into the treatment of advanced bladder cancer
• prIME Points
Conference Objectives are :
After successful completion of this educational activity, participants should be able to:
• Assess the role of immunotherapy and the timing of treatment for patients with bladder cancer • Identify patterns of response and adverse events associated with immunotherapy in the treatment of bladder cancer • Assess evidence associated with the role of biomarkers in the treatment of bladder cancers
Additional details will be posted as soon as they are available.
The target audience for this medical event is specifically designed to meet the needs of practicing medical oncologists, surgical and radiation oncologists, urologists, and other healthcare professionals involved in the treatment of patients with genitourinary malignancies. This CME Conference has been approved for a maximum of 0.5 AMA PRA Category 1 Credits.
Topics:
• Getting to grips with the immune response and cancer treatment
• A step change in the therapeutic options for advanced bladder cancer
• Building on the foundations of success: Rational integration of immunotherapy into the treatment of advanced bladder cancer
• prIME Points
Conference Objectives are :
After successful completion of this educational activity, participants should be able to:
• Assess the role of immunotherapy and the timing of treatment for patients with bladder cancer • Identify patterns of response and adverse events associated with immunotherapy in the treatment of bladder cancer • Assess evidence associated with the role of biomarkers in the treatment of bladder cancers
Additional details will be posted as soon as they are available.
SPECIALITIES
Oncology
Quick Links